ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-OR40

Kidney Volume and Risk of Incident CKD

Session Information

Category: CKD (Non-Dialysis)

  • 2301 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Authors

  • Wu, Jianhan, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada
  • Wang, Yifan, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada
  • Vlasschaert, Caitlyn, Queen's University, Kingston, Ontario, Canada
  • Lali, Ricky, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada
  • Feiner, James, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada
  • Gaheer, Pukhraj Singh, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada
  • Yang, Serena, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada
  • Perrot, Nicolas, Population Health Research Institute, Hamilton, Ontario, Canada
  • Chong, Michael R., Population Health Research Institute, Hamilton, Ontario, Canada
  • Pare, Guillaume, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada
  • Lanktree, Matthew Bruce, St. Joseph Health Care Hamilton, Hamilton, Ontario, Canada
Background

Low total kidney volume (TKV) is a risk factor for CKD. However, evaluations of causal inference and prognostic utility beyond traditional biomarkers are lacking.

Methods

TKV of 34,595 White British ancestry participants were derived from the UK Biobank. Association with incident CKD were assessed with Cox proportional hazard models. Prognostic thresholds for CKD risk stratification were identified using a modified Mazumdar method with bootstrap resampling. Overall improvement in model performance was assessed using likelihood ratio test. Risk reclassification was evaluated with 5-fold cross-validation. Bidirectional associations of genetically predicted TKV with kidney traits were assessed using two-sample Mendelian randomization (MR).

Results

Adjusted for eGFR and albuminuria, a lower TKV of 10 mL was associated with a 6% higher risk of incident CKD (HR 1.06, 95% CI 1.03 to 1.08, P = 5.8 x 10-6). Individuals below the prognostic threshold of body surface area adjusted TKV (BSA-TKV) at 119 mL/m2 (10th percentile) exhibited 2.8-fold (95% CI 2.03 to 3.85, P = 2.9 x 10-10) higher risk of incident CKD after accounting for eGFR, albuminuria, and traditional risk factors. Addition of BSA-TKV improved model performance of the CKD Prognosis Consortium Incident CKD Risk Score (likelihood ratio P = 4.8 x 10-14) and improved reclassification of high-risk prognostication at a rate of 1 per 3.3 cases (95% CI 3.1 to 3.6). In MR, a lower genetically predicted TKV by 10 mL was associated with 10% higher CKD risk (OR 1.10, 95% CI 1.06 to 1.14, P = 1.3 x 10-7). Reciprocally, an elevated risk of genetically predicted CKD by 2-fold was associated with a lower TKV by 7.88 mL (95% CI -9.81 to -5.95, P = 1.2 x 10-15).

Conclusion

Kidney volume was associated with incident CKD independent of traditional risk factors including baseline eGFR and albuminuria. Mendelian randomization demonstrated a bidirectional relationship between kidney volume and CKD.

Funding

  • Government Support – Non-U.S.